Genoil (GNOLF) Common Equity (2009 - 2025)

Genoil (GNOLF) has 14 years of Common Equity data on file, last reported at -$508876.0 in Q4 2025.

• On a quarterly basis, Common Equity fell 56.64% year-over-year to -$508876.0 in Q4 2025; TTM through Dec 2025 was -$508876.0, a 56.64% decrease from a year earlier, with the FY2025 full-year figure at -$508876.0, down 56.64% from the prior year.
• Common Equity for Q4 2025 stood at -$508876.0, up from -$538229.0 in the prior quarter.
• Over the last five years, Common Equity for GNOLF reached as high as $349783.0 in Q2 2023 and fell as low as -$11.1 million in Q1 2023.
• Historically, Common Equity has averaged -$2.5 million across 5 years, with a median of -$246025.5 in 2024.
• On a YoY basis, Common Equity climbed as much as 103.9% in 2023 and fell as far as 3953.26% in 2023.
• Year by year, Common Equity stood at -$9.0 million in 2021, then declined by 21.56% to -$11.0 million in 2022, then soared by 98.77% to -$135320.0 in 2023, then slumped by 140.08% to -$324875.0 in 2024, then sank by 56.64% to -$508876.0 in 2025.
• Per Business Quant data, the three most recent Common Equity figures were -$508876.0 in Q4 2025, -$538229.0 in Q3 2025, and -$453610.0 in Q2 2025.